tumor sequencing
Germany to Test Genomics-Based Precision Medicine for Cancer, Rare Disease in National Pilot Project
Premium
With reimbursement from public health insurance, the "model project" will run for at least five years and examine the utility of genomic sequencing for advanced cancer and rare disease patients.
A comparison for 144 solid tumor samples showed a "high degree of alignment" with FoundationOne CDx and better calling of CNAs than Illumina's TSO 500.
Agilent, National Cancer Center Singapore to Collaborate on Profiling Cancers Prevalent in Asia
The agreement will aid research into tumor genomes and provide data that can be applied in patient care, clinical trials, and diagnostics development.
Myriad Genetics, Intermountain Precision Genomics Obtain NY Certification for Solid Tumor Testing
The NYS certification enables the companies to offer solid tumor testing through the Precise Oncology Solutions suite in all 50 states.
Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test
The collaboration between Sophia and Memorial Sloan Kettering Cancer Center aims to offer new testing and analytics capabilities to clinicians and researchers.